AA
AZN icon

Addison Advisors’s AstraZeneca AZN Stock Holding History

Addison Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$171K Sell
865
-3
-0.3% -$578 0.04% 241
2025
Q4 		$160K Buy
868
+32
+4% +$5.61K 0.04% 253
2025
Q3 		$128K Buy
836
+69
+9% +$10.4K 0.03% 282
2025
Q2 		$107K Sell
767
-121
-14% -$17K 0.03% 301
2025
Q1 		$130K Buy
888
+21
+2% +$3.04K 0.04% 262
2024
Q4 		$114K Sell
867
-5
-0.6% -$700 0.03% 283
2024
Q3 		$136K Buy
872
+93
+12% +$15K 0.04% 266
2024
Q2 		$121K Buy
779
+248
+47% +$37.3K 0.04% 265
2024
Q1 		$72K Buy
531
+33
+7% +$4.37K 0.02% 321
2023
Q4 		$67.1K Buy
498
+133
+36% +$17.3K 0.03% 317
2023
Q3 		$49.4K Buy
365
+116
+47% +$15.8K 0.02% 322
2023
Q2 		$35.6K Buy
249
+17
+7% +$2.5K 0.02% 358
2023
Q1 		$32.1K Sell
232
-19
-8% -$2.56K 0.02% 348
2022
Q4 		$34K Sell
251
-202
-45% -$25.3K 0.02% 321
2022
Q3 		$50K Buy
453
+16
+4% +$2.03K 0.03% 262
2022
Q2 		$58K Sell
437
-107
-20% -$14K 0.04% 242
2022
Q1 		$72K Buy
544
+267
+96% +$32K 0.04% 238
2021
Q4 		$32K Buy
277
+260
+1,529% +$30.6K 0.02% 283
2021
Q3 		$2K Buy
17
+8
+89% +$931 ﹤0.01% 371
2021
Q2 		$1K Buy
+9
New +$987 ﹤0.01% 376
2020
Q4 		$1K Buy
+9
New +$953 ﹤0.01% 361

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Addison Advisors's AZN Position: Q1 2026 in Review

Addison Advisors reduced its AstraZeneca (AZN) stake by 0.35% in Q1 2026, selling an estimated $578 and leaving 865 shares worth $171K. The position accounts for 0.04% of the portfolio, ranked #241.

Addison Advisors first reported a position in AZN in Q4 2020 and has held it in 21 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Addison Advisors held 865 shares of AstraZeneca worth $171K as of Q1 2026.
  • Addison Advisors sold 3 AstraZeneca shares in Q1 2026, an estimated $578.
  • AstraZeneca made up 0.04% of Addison Advisors's portfolio in Q1 2026, its #241 holding.
  • Addison Advisors first reported a position in AstraZeneca in Q4 2020 and has held it in 21 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.